How a drug development plan can save your biotech money
The drug development industry has seen a major shift of clinical activity away from large pharmaceutical companies in favour of…
Accelerating Clinical Trials
Latest in
Accelerating Clinical Trials
Partner content
The benefit of running clinical trials in Asia-Pacific for biotech companies
According to Frost & Sullivan, the CRO market is forecast to grow to US$ 71.7billion by 2024 (+8% CAGR 19-24F).…
Partner content
Is Australia the future for successful first-in-human clinical studies?
The number of biotech-sponsored clinical trials in Australia has grown by more than +10% on average each year between 2017…